MSDL Q1 2026 Earnings Narrow EPS Beat in a Challenging Rate Environment Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107 Ryan Specialty Holdings Inc RYAN Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Pullback DKS Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher DVLT Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed Stock Surges 11